New Results
Advax adjuvant formulations promote protective immunity against aerosol Mycobacterium tuberculosis in the absence of deleterious inflammation and reactogenicity
View ORCID ProfileDiana H. Quan, Claudio Counoupas, Gayathri Nagalingam, Rachel Pinto, Nikolai Petrovsky, Warwick J. Britton, James A. Triccas
doi: https://doi.org/10.1101/2020.10.01.323105
Diana H. Quan
1Discipline of Infectious Diseases and Immunology, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, 2006, NSW, Australia
2Tuberculosis Research Program, Centenary Institute, The University of Sydney, 2006, NSW, Australia
Claudio Counoupas
1Discipline of Infectious Diseases and Immunology, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, 2006, NSW, Australia
2Tuberculosis Research Program, Centenary Institute, The University of Sydney, 2006, NSW, Australia
Gayathri Nagalingam
1Discipline of Infectious Diseases and Immunology, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, 2006, NSW, Australia
2Tuberculosis Research Program, Centenary Institute, The University of Sydney, 2006, NSW, Australia
Rachel Pinto
1Discipline of Infectious Diseases and Immunology, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, 2006, NSW, Australia
2Tuberculosis Research Program, Centenary Institute, The University of Sydney, 2006, NSW, Australia
Nikolai Petrovsky
3Department of Endocrinology, Flinders University, Adelaide, Australia and Vaxine Pty Ltd, Adelaide 5042, Australia
Warwick J. Britton
1Discipline of Infectious Diseases and Immunology, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, 2006, NSW, Australia
2Tuberculosis Research Program, Centenary Institute, The University of Sydney, 2006, NSW, Australia
James A. Triccas
1Discipline of Infectious Diseases and Immunology, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, 2006, NSW, Australia
2Tuberculosis Research Program, Centenary Institute, The University of Sydney, 2006, NSW, Australia
4Department of Clinical Immunology, Royal Prince Alfred Hospital, Camperdown, 2050, NSW, Australia

Article usage
Posted October 01, 2020.
Advax adjuvant formulations promote protective immunity against aerosol Mycobacterium tuberculosis in the absence of deleterious inflammation and reactogenicity
Diana H. Quan, Claudio Counoupas, Gayathri Nagalingam, Rachel Pinto, Nikolai Petrovsky, Warwick J. Britton, James A. Triccas
bioRxiv 2020.10.01.323105; doi: https://doi.org/10.1101/2020.10.01.323105
Advax adjuvant formulations promote protective immunity against aerosol Mycobacterium tuberculosis in the absence of deleterious inflammation and reactogenicity
Diana H. Quan, Claudio Counoupas, Gayathri Nagalingam, Rachel Pinto, Nikolai Petrovsky, Warwick J. Britton, James A. Triccas
bioRxiv 2020.10.01.323105; doi: https://doi.org/10.1101/2020.10.01.323105
Subject Area
Subject Areas
- Biochemistry (5269)
- Bioengineering (3678)
- Bioinformatics (15796)
- Biophysics (7257)
- Cancer Biology (5629)
- Cell Biology (8099)
- Clinical Trials (138)
- Developmental Biology (4768)
- Ecology (7518)
- Epidemiology (2059)
- Evolutionary Biology (10578)
- Genetics (7733)
- Genomics (10137)
- Immunology (5194)
- Microbiology (13914)
- Molecular Biology (5387)
- Neuroscience (30783)
- Paleontology (215)
- Pathology (879)
- Pharmacology and Toxicology (1525)
- Physiology (2254)
- Plant Biology (5024)
- Synthetic Biology (1388)
- Systems Biology (4148)
- Zoology (812)